PAVmed (PAVM) Net Margin (2021 - 2025)

PAVmed's Net Margin history runs 5 years deep, the most recent figure standing at 2261.73% for Q4 2025.

• In Q4 2025, Net Margin fell 1572173.0% year-over-year to 2261.73%; the TTM figure through Dec 2025 stood at 3773.0% (down 271165.0% YoY), while the FY2025 annual figure was 3774.0%, down 484131.0% from the prior year.
• Net Margin was 2261.73% for Q4 2025 at PAVmed, up from 126560.0% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 221187.5% in Q1 2025 to a low of 221800.0% in Q2 2025.
• Historically, Net Margin has averaged 13101.1% across 5 years, with a median of 4899.33% in 2021.
• Biggest YoY gain for Net Margin was 22344374 bps in 2025; the steepest drop was 22068580 bps in 2025.
• A 5-year view of Net Margin shows it stood at 5761.67% in 2021, then tumbled by 218 bps to 18332.14% in 2022, then soared by 92 bps to 1516.21% in 2023, then soared by 988 bps to 13460.0% in 2024, then sank by 117 bps to 2261.73% in 2025.
• The last three Net Margin figures came in at 2261.73% (Q4 2025), 126560.0% (Q3 2025), and 221800.0% (Q2 2025), per Business Quant data.